These processes characterizing DMD pathology, together with the increase of HDAC activity, led to the hypothesis that epigenetic treatments, based on pan-HDACi, could represent an encouraging approach to reduce the DMD progression by enhancing the formation of multinucleated myotubes and therefore of new muscle fibers [124,162,163]. Here, HDAC9 is linked to Duchenne muscular dystrophy.